Randomized Phase III Study to Assess Efficacy and Safety of Adjuvant CAPOX with or without Bevacizumab in Patients after Resection of Colorectal Liver Metastases: HEPATICA study

by Nikol Snoeren, Richard van Hillegersberg, Sander B. Schouten, Andre M. Bergman, Erikv van Werkhoven, Otilia Dalesio, Rob A.E.M. Tollenaar, Henk M. Verheul, Joost van der Sijp, Inne H.M. Borel Rinkes, E.E. Voest
Published 2017-02-01